Identification of Specific Chondroitin Sulfate Species in Cutaneous Autoimmune Disease

Overview

Journal J Histochem Cytochem

Publisher Sage Publications

Specialty Biochemistry

Date 2011 Aug 2

PMID 21804080

Citations 11

Authors

Jessica S Kim

Victoria P Werth

Affiliations

Soon will be listed here.

Abstract

Cutaneous lupus erythematosus and dermatomyositis (DM) are chronic inflammatory diseases of the skin with accumulated dermal mucin. Earlier work has shown chondroitin sulfate (CS) accumulation within the dermis of discoid lupus erythematosus (DLE), subacute cutaneous lupus erythematosus (SCLE), and DM lesions compared with control skin. Immunohistochemistry for C4S revealed a greater density in DLE and DM lesions, whereas SCLE lesions did not differ from controls. Scleredema and scleromyxedema are attributed to increased hyaluronic acid, and lesional samples from these diseases also demonstrated accumulated dermal C4S. Interferon-γ and interleukin-1α, but not interferon-α, treatment of cultured dermal fibroblasts induced mRNA expression of CHST-11, which attaches sulfates to the 4-position of unsulfated chondroitin. These studies on possible CS core proteins revealed that serglycin, known to have C6S side chains in endothelial cells, had greater density within DM dermal endothelia but not in DLE or SCLE, following the pattern of C6S overexpression reported previously. CD44 variants expand the CS binding repertoire of the glycoprotein; CD44v7 co-localized to the distribution of C4S in DLE lesions, a finding not observed in DM, SCLE lesions, or controls. Because C4S and C6S have immunologic effects, their dysregulation in cutaneous mucinoses may contribute to the pathogenesis of these disorders.

Citing Articles

[Differential diagnosis of sclerosing skin diseases: scleredema adultorum of Buschke].

Pfeiffer C, Sunderkotter C Dermatologie (Heidelb). 2024; 75(3):232-236.

PMID: 38347238 DOI: 10.1007/s00105-024-05305-y.

Systemic Lupus Erythematosus Patients with DNASE1L3·Deficiency Have a Distinctive and Specific Genic Circular DNA Profile in Plasma.

Gerovska D, Arauzo-Bravo M Cells. 2023; 12(7).

PMID: 37048133 PMC: 10093232. DOI: 10.3390/cells12071061.

The Interplay of Glycosaminoglycans and Cysteine Cathepsins in Mucopolysaccharidosis.

David A, Chazeirat T, Saidi A, Lalmanach G, Lecaille F Biomedicines. 2023; 11(3).

PMID: 36979788 PMC: 10045161. DOI: 10.3390/biomedicines11030810.

The Alterations and Roles of Glycosaminoglycans in Human Diseases.

Wang Q, Chi L Polymers (Basel). 2022; 14(22).

PMID: 36433141 PMC: 9694910. DOI: 10.3390/polym14225014.

Mass spectrometric analysis of chondroitin sulfate-linked peptides.

Ramarajan M, Saraswat M, Budhraja R, Garapati K, Raymond K, Pandey A J Proteins Proteom. 2022; 13(4):187-203.

PMID: 36213313 PMC: 9526814. DOI: 10.1007/s42485-022-00092-3.

References

Weingart C, Nelson P, Kramer B, Mack M . Dose dependent effects of platelet derived chondroitinsulfate A on the binding of CCL5 to endothelial cells. BMC Immunol. 2008; 9:72. PMC: 2614936. DOI: 10.1186/1471-2172-9-72. View

Haynes B, Liao H, Patton K . The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells. 1991; 3(9):347-50. View

Campo G, Avenoso A, Campo S, Angela D, Ferlazzo A, Calatroni A . TNF-alpha, IFN-gamma, and IL-1beta modulate hyaluronan synthase expression in human skin fibroblasts: synergistic effect by concomital treatment with FeSO4 plus ascorbate. Mol Cell Biochem. 2006; 292(1-2):169-78. DOI: 10.1007/s11010-006-9230-7. View

Kulseth M, Kolset S, Ranheim T . Stimulation of serglycin and CD44 mRNA expression in endothelial cells exposed to TNF-alpha and IL-1alpha. Biochim Biophys Acta. 1999; 1428(2-3):225-32. DOI: 10.1016/s0304-4165(99)00096-3. View

Rongioletti F, Rebora A . Cutaneous mucinoses: microscopic criteria for diagnosis. Am J Dermatopathol. 2001; 23(3):257-67. DOI: 10.1097/00000372-200106000-00022. View

Chang L, Maheshwari P, Werth S, Schaffer L, Head S, Kovarik C . Identification and molecular analysis of glycosaminoglycans in cutaneous lupus erythematosus and dermatomyositis. J Histochem Cytochem. 2011; 59(3):336-45. PMC: 3201158. DOI: 10.1369/0022155410398000. View

Xu C, Jin H, Chung Y, Shin J, Woo M, Lee K . Chondroitin sulfate extracted from the Styela clava tunic suppresses TNF-alpha-induced expression of inflammatory factors, VCAM-1 and iNOS by blocking Akt/NF-kappaB signal in JB6 cells. Cancer Lett. 2008; 264(1):93-100. DOI: 10.1016/j.canlet.2008.01.022. View

Rachmilewitz J, Tykocinski M . Differential effects of chondroitin sulfates A and B on monocyte and B-cell activation: evidence for B-cell activation via a CD44-dependent pathway. Blood. 1998; 92(1):223-9. View

Gandhi N, Mancera R . The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des. 2008; 72(6):455-82. DOI: 10.1111/j.1747-0285.2008.00741.x. View

10.

Krathen M, Fiorentino D, Werth V . Dermatomyositis. Curr Dir Autoimmun. 2008; 10:313-32. PMC: 3928019. DOI: 10.1159/000131751. View

11.

Cichy J, Kulig P, Pure E . Regulation of the release and function of tumor cell-derived soluble CD44. Biochim Biophys Acta. 2005; 1745(1):59-64. DOI: 10.1016/j.bbamcr.2005.02.006. View

12.

Deepa S, Kalayanamitra K, Ito Y, Kongtawelert P, Fukui S, Yamada S . Novel sulfated octa- and decasaccharides from squid cartilage chondroitin sulfate E: sequencing and application for determination of the epitope structure of the monoclonal antibody MO-225. Biochemistry. 2007; 46(9):2453-65. DOI: 10.1021/bi602374m. View

13.

Dechert T, Ducale A, Ward S, Yager D . Hyaluronan in human acute and chronic dermal wounds. Wound Repair Regen. 2006; 14(3):252-8. DOI: 10.1111/j.1743-6109.2006.00119.x. View

14.

Postlethwaite A, Smith Jr G, Lachman L, Endres R, Poppleton H, Hasty K . Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by interleukin 1. Induction of hyaluronic acid synthesis by natural and recombinant interleukin 1s and synthetic interleukin 1 beta peptide 163-171. J Clin Invest. 1989; 83(2):629-36. PMC: 303724. DOI: 10.1172/JCI113927. View

15.

Tiedemann K, Olander B, Eklund E, Todorova L, Bengtsson M, Maccarana M . Regulation of the chondroitin/dermatan fine structure by transforming growth factor-beta1 through effects on polymer-modifying enzymes. Glycobiology. 2005; 15(12):1277-85. DOI: 10.1093/glycob/cwj027. View

16.

Leigh C, Palechek P, Knutson J, McCarthy J, Cohen M, Argenyi Z . CD44 expression in benign and malignant nevomelanocytic lesions. Hum Pathol. 1996; 27(12):1288-94. DOI: 10.1016/s0046-8177(96)90339-1. View

17.

Ito Y, Hikino M, Yajima Y, Mikami T, Sirko S, von Holst A . Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide library. Glycobiology. 2004; 15(6):593-603. DOI: 10.1093/glycob/cwi036. View

18.

Xiao Z, Visentin G, Dayananda K, Neelamegham S . Immune complexes formed following the binding of anti-platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion. Blood. 2008; 112(4):1091-100. PMC: 2515144. DOI: 10.1182/blood-2008-04-153288. View

19.

Wittig B, Johansson B, Zoller M, Schwarzler C, Gunthert U . Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7). J Exp Med. 2000; 191(12):2053-64. PMC: 2193202. DOI: 10.1084/jem.191.12.2053. View

20.

Del Pozo J, Almagro M, Martinez W, Yebra-Pimentel M, Garcia-Silva J, Pena-Penabad C . Dermatomyositis and mucinosis. Int J Dermatol. 2001; 40(2):120-4. DOI: 10.1046/j.1365-4362.2001.01060.x. View